Effect of dietary supplementation on the prognostic value of urinary and serum 8-isoprostaglandin F2αin chemically-induced mammary carcinogenesis in the rat

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Bobrowska, Barbara ^a   Tokarz, Andrzej ^a   Biaek, Sawomir ^a   Seweryn, Magorzata ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; COPPER DERIVATIVE; DIMETHYLBENZ[A]ANTHRACENE; GENISTEIN; POLYPHENOL DERIVATIVE; RESVERATROL; ZINC DERIVATIVE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; CARCINOGEN; COPPER; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA; STILBENE DERIVATIVE; TUMOR MARKER; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; CHEMICALLY INDUCED DISORDER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; NONHUMAN; PROGNOSIS; PROSTAGLANDIN BLOOD LEVEL; RAT; URINALYSIS; URINE LEVEL; ADENOCARCINOMA; ANIMAL; BLOOD; EXPERIMENTAL NEOPLASM; SPRAGUE DAWLEY RAT; URINE;

ANIMALIA; RATTUS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ANIMALS; CARCINOGENS; COPPER; DIETARY SUPPLEMENTS; DINOPROST; FEMALE; GENISTEIN; MAMMARY NEOPLASMS, EXPERIMENTAL; PROGNOSIS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; TUMOR MARKERS, BIOLOGICAL; ZINC;

EID: 79952106999     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-40     Document Type: Article

References (19)

1. Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene. ACSD Barros ENK Muranaka LJ Mori CHT Pelizon K Iriya G Giocondo JA Pinotti, Rev Hosp Clin Fac Med S Paulo 2004 59 257 261 15543396
2. Biomarkers. RH Griffiths L Møller G Bartosz A Bast C Bertoni-Freddari A Collins M Cooke S Coolen G Haenen AM Hoberg S Loft J Lunec R Oliski J Parry A Pompella H Poulsen H Verhagen SB Astley, Mol Aspects Med 2002 23 101 208 10.1016/S0098-2997(02)00017-1 12079771 (Pubitemid 34669882)
3. 2level in Behcet's disease. NC Ozdol A Ates OT Aydintug M Melli, Prostag Oth Lipid M 2005 78 96 106 10.1016/j.prostaglandins.2005.04.002 (Pubitemid 41638039)
4. Zinc as an anti-tumor agent in prostate cancer and in other cancers. RB Franklin LC Costello, Arch Biochem Biophys 2007 463 211 217 10.1016/j.abb.2007. 02.033 17400177 (Pubitemid 47030335)
5. Minimization of Free Radical Damage by Metal Catalysis of Multivitamin/Multimineral Supplements. AB Rabovsky AM Komarov JS Ivie GR Buettner, Nutr J 2010 9 61 10.1186/1475-2891-9-61 21092298
6. Mechanisms of cancer chemoprevention by soy isoflavone genistein. FH Sarkar Y Li, Cancer Metast Rev 2002 21 265 280 10.1023/A:1021210910821 (Pubitemid 36071914)
7. Dietary agents in cancer prevention: flavonoids and isoflavonoids. DF Birt S Hendrich W Wang, Pharmacol Therapeut 2001 90 157 177 10.1016/S0163- 7258(01)00137-1 (Pubitemid 32913477)
8. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. MA Soobrattee VS Neergheen A Luximon-Ramma OI Aruoma T Bahorun, Mutat Res 2005 579 200 213 16126236 (Pubitemid 41540144)
9. Biological effects of resveratrol. L Fremont, Life Sci 2000 66 663 673 10.1016/S0024-3205(99)00410-5 10680575
10. Dietary intake and sources of isoflavones among Japanese. K Wakai I Egami K Kato T Kawamura A Tamakoshi Y Lin T Nakayama M Wada Y Ohno, Nutr Cancer 1999 47 141 147
11. AIN-93 purified diets for laboratory rodents: final raport of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. PG Reeves FH Nielsen GC Fahey, J Nutr 1993 123 1939 1951 8229312 (Pubitemid 23342492)
12. 4poisoning. MB Kadiiska BC Gladen DD Baird LB Graham CE Parker BN Ames S Basu GA FitzGerald JA Lawson LJ Marnett JD Morrow DM Murray J Plastaras LJ Roberts J Rokach MK Shigenaga J Sun PB Walter KB Tomer JC Barrett RP Mason, Free Radical Bio Med 2005 38 711 718 10.1016/j.freeradbiomed.2004.10.024 (Pubitemid 40249741)
13. The effect of polyphenols on markers of oxidative damage and DMBA induced carcinogenesis in rats. B Bobrowska A Tokarz G Grynkiewicz S Bialek M Matysiak T Bat-Erdene, J Food Lipids 2009 16 103 112 10.1111/j.1745-4522.2009.01135.x
14. Zinc, antioxidant system and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. A Formigari P Irato A Santon, Comp Biochem Phys C 2007 146 443 459 (Pubitemid 47494685)
15. Plasma extracellular superoxide dismutase activity in healthy pregnant women is not influenced by zinc supplementation. T Tamura KL Olin RL Goldenberg KE Johnston MB Dubard CL Keen, Biol Trace Elem Res 2001 80 107 113 10.1385/BTER:80:2:107 11437176 (Pubitemid 32548081)
16. Influence of chronic zinc supplementation on biochemical variables and circadian rhythms in wistar rats. P Subramanian S Sivabalan VP Menon K Vasudevan, Nutr Res 2000 20 413 425 10.1016/S0271-5317(00)00134-2 (Pubitemid 30183207)
17. 2-isoprostanes mediate high glucose-induced TGF- synthesis and glomerular proteinuria in experimental type I diabetes. A Montero KA Munger RZ Khan JM Valdivielso JD Morrow A Guasch FN Ziyadeh KF Badr, Kidney Int 2000 58 1963 1972 10.1111/j.1523-1755.2000.00368.x 11044216
18. Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects. RA Caccetta V Burke TA Mori LJ Beilin IB Puddey KD Croft, Free Radical Bio Med 2001 30 636 642 10.1016/S0891-5849(00) 00497-4 (Pubitemid 32280789)
19. Plasma and dietary carotenoids are associated with reduced oxidative stress in women previously treated for breast cancer. CA Thomson NR Stendell-Hollis CL Rock EC Cussler SW Flatt JP Pierce, Cancer Epidemiol Biomarkers Prev 2007 16 10 2008 2015 10.1158/1055-9965.EPI-07-0350 17932348 (Pubitemid 47621174)